rtki cpd has been researched along with apomorphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barbeau, A; Beaulieu, JM; De Koninck, Y; Godin, AG; Swift, JL; Wiseman, PW | 1 |
2 other study(ies) available for rtki cpd and apomorphine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Spatial intensity distribution analysis (SpIDA): a new tool for receptor tyrosine kinase activation and transactivation quantification.
Topics: Apomorphine; Cell Line; ErbB Receptors; Fluorescent Antibody Technique; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Ligands; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Imaging; Neurons; Protein Multimerization; Quinazolines; Receptor, trkB; Receptors, Dopamine; Recombinant Fusion Proteins; Software; Transcriptional Activation; Tyrphostins | 2013 |